87 related articles for article (PubMed ID: 7681884)
1. [Antigenicities of groups I and II hepatitis C virus].
Kohara M
Nihon Rinsho; 1993 Feb; 51(2):338-43. PubMed ID: 7681884
[TBL] [Abstract][Full Text] [Related]
2. [Specific antibody assay for genotyping of hepatitis C virus].
Kohara M
Nihon Rinsho; 1994 Jul; 52(7):1728-33. PubMed ID: 7521411
[TBL] [Abstract][Full Text] [Related]
3. Antigenicities of Group I and II hepatitis C virus polypeptides--molecular basis of diagnosis.
Tsukiyama-Kohara K; Yamaguchi K; Maki N; Ohta Y; Miki K; Mizokami M; Ohba K; Tanaka S; Hattori N; Nomoto A
Virology; 1993 Feb; 192(2):430-7. PubMed ID: 7678473
[TBL] [Abstract][Full Text] [Related]
4. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J
Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977
[TBL] [Abstract][Full Text] [Related]
5. Sequence analysis of NS3 protease gene in clinical strains of hepatitis C virus.
Lodrini S; Bagaglio S; Canducci F; De Mitri MS; Andreone P; Loggi E; Lazzarin A; Clementi M; Morsica G
J Biol Regul Homeost Agents; 2003; 17(2):198-204. PubMed ID: 14518724
[TBL] [Abstract][Full Text] [Related]
6. Significance of specific antibody assay for genotyping of hepatitis C virus.
Tanaka T; Tsukiyama-Kohara K; Yamaguchi K; Yagi S; Tanaka S; Hasegawa A; Ohta Y; Hattori N; Kohara M
Hepatology; 1994 Jun; 19(6):1347-53. PubMed ID: 7514558
[TBL] [Abstract][Full Text] [Related]
7. Molecular cloning of the immunodominant regions of hepatitis C virus type III and IV by immunoscreening.
Sato A; Kazami J; Arima T; Nakamura H; Kunitomo T
Acta Virol; 1993; 37(2-3):132-42. PubMed ID: 7692715
[TBL] [Abstract][Full Text] [Related]
8. Genomic typing of hepatitis C viruses from Korean patients: implications of genome variation in the E2/NS1 region.
Cho SH; Yoon JI; Chang JE; Ahn BM; Lee CH; Lee YI
Biochem Biophys Res Commun; 1993 Oct; 196(2):780-8. PubMed ID: 8240354
[TBL] [Abstract][Full Text] [Related]
9. Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.
López-Labrador FX; He XS; Berenguer M; Cheung RC; González-Candelas F; Wright TL; Greenberg HB
J Med Virol; 2004 Apr; 72(4):575-85. PubMed ID: 14981760
[TBL] [Abstract][Full Text] [Related]
10. Lymphoproliferative responses to hepatitis C virus core, E1, E2, and NS3 in patients with chronic hepatitis C infection treated with interferon alfa.
Leroux-Roels G; Esquivel CA; DeLeys R; Stuyver L; Elewaut A; Philippé J; Desombere I; Paradijs J; Maertens G
Hepatology; 1996 Jan; 23(1):8-16. PubMed ID: 8550052
[TBL] [Abstract][Full Text] [Related]
11. Conserved hepatitis C virus sequences are highly immunogenic for CD4(+) T cells: implications for vaccine development.
Lamonaca V; Missale G; Urbani S; Pilli M; Boni C; Mori C; Sette A; Massari M; Southwood S; Bertoni R; Valli A; Fiaccadori F; Ferrari C
Hepatology; 1999 Oct; 30(4):1088-98. PubMed ID: 10498664
[TBL] [Abstract][Full Text] [Related]
12. Conservation of hepatitis C virus nonstructural protein 3 amino acid sequence in viral isolates during liver transplantation.
Mello IM; Thumann C; Schvoerer E; Soulier E; Pinho JR; Silvestre DA; Queiroz AT; Wolf P; Baumert TF; Keller FS; Pereira CA
J Viral Hepat; 2009 Oct; 16(10):732-7. PubMed ID: 19486468
[TBL] [Abstract][Full Text] [Related]
13. [Determination of the nucleotide sequence of the Russian variant of the hepatitis C virus].
Vasilev VB; Viazov SO; Kotova EIu; Nosikov VV
Mol Gen Mikrobiol Virusol; 1994; (1):33-7. PubMed ID: 8133850
[TBL] [Abstract][Full Text] [Related]
14. Sequence analysis of hepatitis C virus variants producing discrepant results with two different genotyping assays.
Prescott LE; Berger A; Pawlotsky JM; Conjeevaram P; Pike I; Simmonds P
J Med Virol; 1997 Nov; 53(3):237-44. PubMed ID: 9365889
[TBL] [Abstract][Full Text] [Related]
15. Changes in hepatitis C virus (HCV) antibody status in patients with chronic hepatitis C after eradication of HCV infection by interferon therapy.
Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kuzuya T; Honda T; Hayashi K; Nakano I; Katano Y; Goto H
Clin Infect Dis; 2005 Mar; 40(6):e49-54. PubMed ID: 15736006
[TBL] [Abstract][Full Text] [Related]
16. Complete nucleotide sequence of genotype 4 hepatitis C viruses isolated from patients co-infected with human immunodeficiency virus type 1.
Franco S; Tural C; Clotet B; Martínez MA
Virus Res; 2007 Feb; 123(2):161-9. PubMed ID: 17023084
[TBL] [Abstract][Full Text] [Related]
17. cDNA cloning of c33-c antigen gene derived from NS3 region of Chinese HCV genome, expression in Escherichia coli and development of HCV EIA second-generation diagnostic kit.
Yang YP; Liu CB; Jin DY; Zhan MY; Tang Q; Xia NS; Cao JY; Li JY
Sci China B; 1994 Feb; 37(2):190-202. PubMed ID: 7520701
[TBL] [Abstract][Full Text] [Related]
18. A human monoclonal antibody specific for the N terminus of the hepatitis C virus nucleocapsid protein.
Cerino A; Boender P; La Monica N; Rosa C; Habets W; Mondelli MU
J Immunol; 1993 Dec; 151(12):7005-15. PubMed ID: 7505020
[TBL] [Abstract][Full Text] [Related]
19. Comparison between homologies of E2/NS1 gene from genotype III Chinese isolates of hepatitis C virus and that from reported isolates.
Wu C; Tao Q
Chin Med J (Engl); 1998 Sep; 111(9):807-9. PubMed ID: 11155671
[TBL] [Abstract][Full Text] [Related]
20. [PCR-based HCV genotyping with type-specific primers derived from core gene and IFN responsiveness].
Okamoto H
Nihon Rinsho; 1994 Jul; 52(7):1699-706. PubMed ID: 7521407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
